STOCK TITAN

Eyenovia to Report Fourth Quarter and Full-Year 2022 Results on Thursday, March 30

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Eyenovia, Inc. (NASDAQ: EYEN) will announce its fourth quarter and full year financial results for 2022 on March 30, 2023, after market close. Following this release, the company will host a conference call and webcast at 4:30 PM ET to discuss the results. Interested participants can join by dialing either 1-877-407-9039 (domestic) or 1-201-689-8470 (international) using conference code 13736709. A live webcast will also be accessible on their investor relations page. The event will be archived on Eyenovia’s website for one year.

Positive
  • None.
Negative
  • None.

Company to host an investor conference call and webcast at 4:30 pm ET

NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs as well as out-licensing for additional indications, today announced that the Company will release financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 30, 2023, after the markets close. Following the release, Eyenovia management will host a conference call and webcast at 4:30 p.m. ET to review the financial and operating results.

Participants should dial 1-877-407-9039 (domestic) or 1-201-689-8470 (international) with the conference code 13736709. A live webcast of the conference call will also be available on the investor relations page of the Company's corporate website at www.eyenovia.com.

To access the Call me™ feature, which avoids having to wait for an operator, click here.

After the live webcast, the event will be archived on Eyenovia’s website for one year.

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia, and myopia progression. For more information, visit www.eyenovia.com.

The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.

Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com

Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363

Eyenovia Media Contact:
Eyenovia, Inc.
Norbert Lowe
Vice President, Commercial Operations
nlowe@eyenovia.com


FAQ

When will Eyenovia report its fourth quarter financial results?

Eyenovia will report its fourth quarter financial results for 2022 on March 30, 2023.

What time is Eyenovia's conference call on March 30, 2023?

The conference call will take place at 4:30 PM ET on March 30, 2023.

How can I join Eyenovia's conference call?

To join the conference call, dial 1-877-407-9039 (domestic) or 1-201-689-8470 (international) and use conference code 13736709.

Where can I find the webcast for Eyenovia's financial results?

The webcast will be available on Eyenovia's investor relations page at www.eyenovia.com.

Eyenovia, Inc.

NASDAQ:EYEN

EYEN Rankings

EYEN Latest News

EYEN Stock Data

9.43M
110.07M
9.99%
13.73%
2.49%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NEW YORK